Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies
Keyword(s):
2020 ◽
Vol 24
(03)
◽
pp. 10-21
◽
Keyword(s):
1996 ◽
Vol 42
(2)
◽
pp. 127-131
◽
1998 ◽
Vol 13
(11-s4)
◽
pp. S315-S319
◽
1998 ◽
Vol 13
(11-s4)
◽
pp. S299-S303
Keyword(s):